Definitive Healthcare Corp. Files 8-K on New Agreement

TL;DR

DHCO signed a new material agreement and took on a financial obligation on Jan 16, 2025.

AI Summary

On January 16, 2025, Definitive Healthcare Corp. filed an 8-K report detailing a material definitive agreement and a direct financial obligation. The filing indicates the company entered into a significant agreement and incurred a financial obligation, though specific details of the agreement and obligation are not provided in this excerpt.

Why It Matters

This filing signals a new material agreement and financial obligation for Definitive Healthcare Corp., which could impact its financial structure and future operations.

Risk Assessment

Risk Level: medium — The filing indicates a material definitive agreement and a direct financial obligation, which inherently carry financial risks that are not fully detailed in this summary.

Key Players & Entities

• Definitive Healthcare Corp. (company) — Registrant
• January 16, 2025 (date) — Date of Report

FAQ

Key Financial Figures

• $0.001 — hich Registered Class A Common Stock, $0.001 par value DH The NASDAQ Stock Marke
• $175 million — Agreement Amendment provides for (i) a $175 million term loan facility (the "Term Facility"
• $50 million — cility (the "Term Facility") and (ii) a $50 million revolving credit facility (the "Revolvi

Filing Documents

• dh-20250116.htm (8-K) — 48KB
• dh-ex10_1.htm (EX-10.1) — 2682KB
• 0000950170-25-006199.txt ( ) — 3217KB
• dh-20250116.xsd (EX-101.SCH) — 30KB
• dh-20250116_htm.xml (XML) — 4KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. On January 16, 2025 (the "Closing Date"), Definitive Healthcare Holdings, LLC, a Delaware limited liability company ("DHH"), an indirect subsidiary of Definitive Healthcare Corp., a Delaware corporation (the "Company"), entered into an amendment to the credit agreement (the "DHH Credit Agreement Amendment"), dated as of September 17, 2021 (as amended by that certain Amendment No. 1, dated as of October 31, 2022, and as further amended, supplemented or otherwise modified from time to time prior to the date hereof, the "Existing Credit Agreement", and as further amended by the DHH Credit Agreement Amendment, the "DHH Credit Agreement"), with Bank of America, N.A., as administrative agent, the lenders party thereto and the other parties specified therein. The DHH Credit Agreement Amendment provides for (i) a $175 million term loan facility (the "Term Facility") and (ii) a $50 million revolving credit facility (the "Revolving Credit Facility" and, together with the Term Facility, collectively, the "Facilities"), the proceeds of which were used to, among other things, repay the remaining portion of the indebtedness outstanding under the Existing Credit Agreement, and to pay related fees and expenses. The loans under the Term Facility and the Revolving Credit Facility mature on January 16, 2030. The Facilities are guaranteed, subject to customary exceptions, by all of DHH's wholly-owned domestic restricted subsidiaries and AIDH Buyer, LLC, a Delaware limited liability company and the direct parent company of DHH ("Holdings"), and are secured by associated collateral agreements that pledge a lien on substantially all of DHH's assets, including fixed assets and intangibles, and the assets of the guarantors, in each case, subject to customary exceptions. The Term Facility is subject to amortization of principal, payable in quarterly installments on the last day of each fiscal quarter, commencing on the last day of

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. 10.1 Amendment No. 2, dated as of January 16, 2025, to Credit Agreement, dated September 17, 2021, by and among Definitive Healthcare Holdings, LLC, AIDH Buyer, LLC, the other loan guarantors from time to time party thereto, Bank of America, N.A., as Administrative Agent, the lenders party thereto and the issuing banks from time to time party thereto. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. DEFINITIVE HEALTHCARE CORP. By: /s/ Richard Booth Name: Richard Booth Title: Chief Financial Officer Date: January 16, 2025

View Full Filing

View this 8-K filing on SEC EDGAR